Capital Management Associates Baxter International Inc Transaction History

Capital Management Associates

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$75.39 - $82.36 $294,021 - $321,204	-3,900 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$78.33 - $90.73 $203,658 - $235,898	-2,600 Reduced 40.0%	3,900 $314,000
Q2 2020 Aug 05, 2020	SELL	$78.66 - $94.14 $7,866 - $9,414	-100 Reduced 1.52%	6,500 $560,000
Q1 2020 May 07, 2020	SELL	$71.57 - $93.3 $14,313 - $18,660	-200 Reduced 2.94%	6,600 $536,000
Q4 2019 Feb 12, 2020	BUY	$76.7 - $88.45 $72,865 - $84,027	950 Added 16.24%	6,800 $569,000
Q2 2019 Aug 08, 2019	SELL	$73.44 - $82.41 $7,344 - $8,241	-100 Reduced 1.68%	5,850 $479,000
Q3 2018 Nov 06, 2018	SELL	$70.71 - $77.75 $14,849 - $16,327	-210 Reduced 3.41%	5,950 $459,000
Q2 2018 Aug 02, 2018	SELL	$63.43 - $75.41 $2,537 - $3,016	-40 Reduced 0.65%	6,160 $455,000
Q4 2017 Feb 06, 2018	SELL	$61.45 - $66.05 $67,595 - $72,655	-1,100 Reduced 15.07%	6,200 $401,000
Q3 2017 Nov 06, 2017	BUY	$59.5 - $64.61 $434,350 - $471,653	7,300	7,300 $458,000

1,007

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Capital Management Associates , based on Form 13F filings with the SEC.

Stay updated on Capital Management Associates with notifications on news.